1099 On Other Exchanges
Symbol
Exchange
1099 is not on other exchanges.

sinopharm group co-h (1099) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SINOPHARM GROUP CO-H (1099)

Related News

No related news articles were found.

sinopharm group co-h (1099) Related Businessweek News

View More BusinessWeek News

sinopharm group co-h (1099) Details

Sinopharm Group Co.Ltd., together with its subsidiaries, distributes pharmaceutical and healthcare products in the People’s Republic of China. The company’s Pharmaceutical Distribution segment offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. This segment distributes medicines, medicine devices, and pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. Its Retail Pharmacy segment operates or franchises a network of retail drug stores. As of December 31, 2015, this segment had 3,080 retail pharmacies, which included 2,128 retail pharmacies operated by company and 952 operated by franchisees. The company’s Other Business segment produces and sells pharmaceutical products, chemical reagents, and laboratory supplies; and distributes medical devices, as well as engages in financial leasing. The company also distributes building decoration, communication, and clothing products, as well as chemical reagents and office supplies; and provides business and medicine consulting, import agency, other miscellaneous services, etc. In addition, it is involved in the real estate development, property rental, planting, and property management activities; provides health consultation, market information consulting and investigation, and convention and exhibition services; and distributes commodities and construction materials. Further, the company provides cargo agency, warehousing, and shipping services; manufactures and trades in Chinese herbal medicines; provides computer, storage, medical, and economic information consulting and technology development services; distributes medical instruments, drinks, and foods; and provides sterile and packaging service to medical instruments. The company was founded in 2003 and is based in Shanghai, China. Sinopharm Group Co.Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

55,869 Employees
Last Reported Date: 09/8/16
Founded in 2003

sinopharm group co-h (1099) Top Compensated Officers

President and Executive Director
Total Annual Compensation: CNY3.2M
Chairman
Total Annual Compensation: CNY3.5M
Head of Auditing Department
Total Annual Compensation: CNY895.0K
Compensation as of Fiscal Year 2015.

sinopharm group co-h (1099) Key Developments

Sinopharm Group Co. Ltd. Announces Executive Changes effective October 28, 2016

The board of directors of Sinopharm Group Co. Ltd. announced that due to change in responsibilities, Mr. Ma Wanjun has tendered his resignation from his positions as secretary to the Board, joint company secretary and authorized representative of the company with effect from 28 October 2016. On the same day, Mr. Liu Yong has been appointed by the Board as the new secretary to the Board, joint company secretary and authorized representative of the company, with effect from 28 October 2016.

Sinopharm Group Co. Ltd. Reports Unaudited Consolidated Group and Company Earnings Results for the Nine Months Ended September 30, 2016

Sinopharm Group Co. Ltd. reported unaudited consolidated group and company earnings results for the nine months ended September 30, 2016. For the period, on group basis, the company reported operating revenue of RMB 191,839,854,664.92 against RMB 169,812,413,223.16 a year ago. Operating profit was RMB 6,400,492,662.81 against RMB 5,421,866,212.07 a year ago. Total profit was RMB 6,865,355,114.86 against RMB 5,583,879,219.40 a year ago. Net profit attributable to equity holders of the company was RMB 3,596,363,193.59 or RMB 1.30 pert basic and diluted share against RMB 2,836,662,832.41 or RMB 1.03 per basic and diluted share a year ago. Net cash flows from operating activities were RMB 78,596,708.77 against RMB 4,149,365,337.51 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 938,877,067.93 against RMB 1,012,445,499.39 a year ago. For the period, on company basis, the company reported operating revenue of RMB 13,629,250,385.33 against RMB 12,505,058,009.09 a year ago. Operating profit was RMB 581,815,639.53 against RMB 929,682,173.57 a year ago. Total profit was RMB 605,771,661.32 against RMB 959,619,502.72 a year ago. Net profit was RMB 532,985,599.71 against RMB 829,502,985.15 a year ago. Net cash flows from operating activities were RMB 1,608,886,602.03 against RMB 4,921,148,030.27 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 129,323,122.65 against RMB 164,283,373.19 a year ago.

Sinopharm Group Co.,Ltd. Approves the Appointment of Ma Ping as a Non-Executive Director

Sinopharm Group Co.,Ltd. at its extraordinary general meeting held on October 18, 2016, approved the appointment of Mr. Ma Ping as a non-executive director of the company with effect from 18 October 2016. The Board considered and approved the appointment of Mr. Ma Ping as a member of the Strategy and Investment Committee under the Board.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1099 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1099.
View Industry Companies
 

Industry Analysis

1099

Industry Average

Valuation 1099 Industry Range
Price/Earnings 19.4x
Price/Sales 0.4x
Price/Book 2.7x
Price/Cash Flow 19.4x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SINOPHARM GROUP CO-H, please visit www.sinopharmholding.com/En. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.